Skip to main content
. 2013 Aug 13;109(5):1117–1122. doi: 10.1038/bjc.2013.468

Table 1. Characteristics of patients.

 
Locally advancedn (%)
Metastaticn (%)
Characteristics n=9 n=12
Age (years)
Median 57 63
Range
23–71
31–73
Sex
Male 3 (33) 4 (33)
Female
6 (67)
8 (67)
Performance status
0 5 (56) 5 (42)
1
4 (44)
7 (58)
Primary tumour localisation
Gland of palate 4 (44) 2 (17)
Lacrimal gland 1 (11) 1 (8)
Submandibular gland 2 (17)
Maxillary sinus gland 1 (11) 2 (17)
Parotid gland 2 (17)
Base of tongue 1 (11)
Nasopharynx 2 (17)
Lung 1 (8)
Tracheal gland
2 (22)

Metastasis localisation
Lung 3
Lymph node 2a
Skin 1
Multiple

6
Histology
Cribriform 4 (44)
Solid 1 (11) 1 (8)
Tubular 1 (8)
Mixed 2 (22) 2 (17)
NA
2 (22)
8 (67)
Grade
1 3 (33) 1 (8)
2 2 (22) 2 (17)
3 2 (22) 1 (8)
NA
2 (22)
8 (67)
Perineural invasion
Yes 2 (22) 2 (17)
No 5 (56) 3 (25)
NA
2 (22)
7 (58)
Tumour stage at diagnosis
T1 2 (16)
T2 1 (11)b 4 (33)
T3 2 (22)b 3 (25)
T4a 1 (8)
T4b
6 (67)c
2 (17)
Nodal stage at diagnosis
N0 9 (100) 9 (75)
N1

3 (25)
Disease stage at enrollment
Stage I 1 (11)
Stage II 2 (22)
Stage IVA 6 (67)
Stage IVC

12 (100)
Site of progression
Lung 1 (11) 6 (50)
Local 4 (44)
Skin   1 (8)
Dura   1 (8)
Bone   1 (8)
Orbit
 
1 (8)
EGFR status
2+ 6 (67) 8 (67)
3+
3 (33)
4 (33)
Best response
CR 2 (22)
PR 2 (22) 5 (42)
SD ⩾18 months 2 (22) 5 (42)
SD <18 months 3 (33) 2 (17)
PD

Abbreviations: CR=complete response; EGFR=epidermal growth factor receptor; NA=not available; PD=progressive disease; PR=partial response; SD=stable disease.

a

Mediastinal and mediastinal+cervical.

b

Refused surgery.

c

Unresectable.